Loading organizations...
Highside Capital Management operates as an investment firm, managing private investment partnerships. The firm primarily allocates capital to public equity markets, employing a nuanced approach to identify and capitalize on opportunities. Its strategy focuses on delivering robust returns for investors through active management and in-depth market analysis.
The company was established in 2004 by Lee Hobson. Hobson brought significant prior experience to Highside, having honed his expertise at prominent financial institutions like Maverick Capital and Goldman Sachs. His insight centered on creating a specialized vehicle for strategic investments in public equities, leveraging a disciplined analytical framework.
Highside Capital Management serves a sophisticated investor base, managing private investment partnerships for institutional clients and high-net-worth individuals. The firm's long-term vision is to consistently generate superior risk-adjusted returns through meticulous research and a deep understanding of public equity market dynamics.
Highside Capital Management has 4 tracked investments across 4 companies. The latest tracked deal is $100.0M Series B in Mythic Therapeutics in December 2021.